EndogenX has entered the pharmaceutical, biotechnology and nutraceutical industries. In addition to finding new molecules, our vision is to find new uses for existing molecules. Many of our proprietary and patented technologies have either recently begun commercialization in foreign countries or are based upon employing well-characterized compounds and off-patent pharmaceuticals in novel ways. Thus, we have effectively minimized the extremely high costs typically associated with the research and discovery of new biotechnologies. Rather than the sole quest for novel developments, we have primarily kept our focus on existing well-profiled branded and generic products along with currently foreign commercialized products as its initial product pipeline mix.

EndogenX is engaged in developing, acquiring, and commercializing novel pharmaceutical, therapeutic, and diagnostic products/applications worldwide. We will outsource manufacturing, but will retain all intellectual property rights to its product pipeline.